Alnylam Pharmaceuticals, Inc. (ALNY) vs Vertex Pharmaceuticals Incorporated (VRTX)

Alnylam Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $31.2B — 4.2× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 30.4× against 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 16.1%) and the higher return on invested capital (24.1% vs 0.00%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 16 and Alnylam Pharmaceuticals, Inc. on 6.